Clinical trial
Furosemide Oral Versus Placebo for Reduction of Hospital Length of Stay in Postpartum Women With Severe Preeclampsia: A Double-Blind, Randomized Controlled Trial
NCT07648251 is registered in ClinicalTrials.gov with Universidad Nacional Autonoma de Honduras as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Furosemide Oral Versus Placebo for Reduction of Hospital Length of Stay in Postpartum Women With Severe Preeclampsia: A Double-Blind, Randomized Controlled Trial
- Lead sponsor
- Universidad Nacional Autonoma de Honduras
- Phase
- Phase 2
- Overall status
- Not yet recruiting
- Start date
- June 15, 2026
- Completion date
- January 15, 2027
- Enrollment
- 186 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
severe preeclampsia